Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives

World Journal of Gastroenterology

Volumn 19, Issue 12, 2013, Pages 1890-1900

  Kim, Beom Kyung ^a,b   Fung, James ^c   Yuen, Man Fung ^c   Kim, Seung Up ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Centre   (South Korea)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Fibroscan; Fibrosis; Liver stiffness; Longitudinal; Outcome; Transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE;

ASCITES; BLEEDING; CHRONIC LIVER DISEASE; DIAGNOSTIC ACCURACY; DISEASE COURSE; ELASTOGRAPHY; HEPATIC ENCEPHALOPATHY; HISTOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; PORTAL HYPERTENSION; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TRANSIENT ELASTOGRAPHY;

EID: 84875577607     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i12.1890     Document Type: Review

References (100)

1. Jang JW. Current status of liver diseases in Korea: liver cirrhosis. Korean J Hepatol 2009; 15 Suppl 6: S40-S49 [PMID: 20037279 DOI: 10.3350/kjhep.2009.15.S6.S40]
2. Lok AS. Hepatitis B: liver fibrosis and hepatocellular carcinoma. Gastroenterol Clin Biol 2009; 33: 911-915 [PMID: 19577871 DOI: 10.1016/j.gcb.2009.06.001]
3. Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 2007; 82: 967-975 [PMID: 17673066 DOI: 10.4065/82.8.967]
4. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990; 99: 1396-1400 [PMID: 2101588]
5. Jin SY. Role of liver biopsy in the assessment of hepatic fibrosis--its utility and limitations. Korean J Hepatol 2007; 13: 138-145 [PMID: 17585187]
6. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618 [PMID: 12385448 DOI: 10.1111/j.1572-0241.2002.06038.x]
7. Abraldes JG, Araujo IK, Turón F, Berzigotti A. Diagnosing and monitoring cirrhosis: Liver biopsy, hepatic venous pressure gradient and elastography. Gastroenterol Hepatol 2012; 35: 488-495 [PMID: 22560536 DOI: 10.1016/ j.gastrohep.2012.02.010]
8. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-847 [PMID: 18334275 DOI: 10.1016/j.jhep.2008.02.008]
9. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, Beaugrand M, Palau R. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-1713 [PMID: 14698338 DOI: 10.1016/j.ultr asmedbio.2003.07.001]
10. Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and metaanalysis. Clin Gastroenterol Hepatol 2007; 5: 1214-1220 [PMID: 17916549 DOI: 10.1016/j.cgh.2007.07.020]
11. Stauber RE, Lackner C. Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C. World J Gastroenterol 2007; 13: 4287-4294 [PMID: 17708599]
12. Kang JK, Cheong JY, Cho SW, Cho JH, Park JS, Kim YB, Kim DJ, Hwang SG, Yang JM, Park YN. Liver stiffness measurement for the diagnosis of hepatic fibrosis in patients with chronic viral hepatitis. Korean J Hepatol 2007; 13: 521-529 [PMID: 18159150 DOI: 10.3350/kjhep.2007.13.4.521]
13. Jung HS, Kim YS, Kwon OS, Ku YS, Kim YK, Choi DJ, Kim JH. Usefulness of liver stiffness measurement for predicting the presence of esophageal varices in patients with liver cirrhosis. Korean J Hepatol 2008; 14: 342-350 [PMID: 18815457 DOI: 10.3350/kjhep.2008.14.3.342]
14. Kim SG, Kim YS, Jung SW, Kim HK, Jang JY, Moon JH, Kim HS, Lee JS, Lee MS, Shim CS, Kim BS. The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease. Korean J Hepatol 2009; 15: 42-51 [PMID: 19346784 DOI: 10.3350/kjhep.2009.15.1.42]
15. Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH. Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease. Korean J Hepatol 2009; 15: 454-463 [PMID: 20037264 DOI: 10.3350/ kjhep.2009.15.4.454]
16. Scott DR, Levy MT. Liver transient elastography (Fibroscan): a place in the management algorithms of chronic viral hepatitis. Antivir Ther 2010; 15: 1-11 [PMID: 20167986 DOI: 10.3851/IMP1474]
17. Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, Bower M, Gazzard B, Nelson M. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol 2010; 44: 214-219 [PMID: 19745758 DOI: 10.1097/MCG.0b013e3181b4af1f]
18. Han KH, Yoon KT. New diagnostic method for liver fibrosis and cirrhosis. Intervirology 2008; 51 Suppl 1: 11-16 [PMID: 18544943 DOI: 10.1159/000122594]
19. Smith JO, Sterling RK. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Aliment Pharmacol Ther 2009; 30: 557-576 [PMID: 19519733 DOI: 10.1111/j.1365-2036.2009.04062.x]
20. Kim BK, do Kim Y, Han KH, Park JY, Kim JK, Paik YH, Lee KS, Chon CY, Ahn SH. Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model. Am J Gastroenterol 2011; 106: 1654-1662, 1730 [PMID: 21691339]
21. Kim SU, Han KH, Ahn SH. Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones. J Gastroenterol Hepatol 2010; 25: 1472-1473 [PMID: 20796140 DOI: 10.1111/j.1440-1746.2010.06432.x]
22. Addley J, Tham TC, Cash WJ. Use of portal pressure studies in the management of variceal haemorrhage. World J Gastrointest Endosc 2012; 4: 281-289 [PMID: 22816007 DOI: 10.4253/ wjge.v4.i7.281]
23. Bosch J, García-Pagán JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000; 32: 141-156 [PMID: 10728801]
24. Suk KT, Kim CH, Park SH, Sung HT, Choi JY, Han KH, Hong SH, Kim DY, Yoon JH, Kim YS, Baik GH, Kim JB, Kim DJ. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis. J Clin Gastroenterol 2012; 46: 880-886 [PMID: 22810110]
25. Keiding S, Vilstrup H. Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis. Scand J Gastroenterol 2002; 37: 960-964 [PMID: 12229973]
26. Rincón D, Lo Iacono O, Tejedor M, Hernando A, Ripoll C, Catalina MV, Salcedo M, Matilla A, Senosiain M, Clemente G, Molinero LM, Albillos A, Bañares R. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis. Scand J Gastroenterol 2012 Aug 8; Epub ahead of print [PMID: 22871085]
27. Pineda JA, Recio E, Camacho A, Macías J, Almodóvar C, González-Serrano M, Merino D, Tellez F, Ríos MJ, Rivero A. Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis. J Acquir Immune Defic Syndr 2009; 51: 445-449 [PMID: 19487952 DOI: 10.1097/QAI.0b013e3181acb675]
28. Wadhawan M, Dubey S, Sharma BC, Sarin SK, Sarin SK. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status. Dig Dis Sci 2006; 51: 2264-2269 [PMID: 17080245 DOI: 10.1007/ s10620-006-9310-2]
29. Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH. Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea. Korean J Hepatol 2008; 14: 150-158 [PMID: 18617762]
30. Hobolth L, Bendtsen F, Møller S. Indications for portal pressure measurement in chronic liver disease. Scand J Gastroenterol 2012; 8-9: 887-892 [PMID: 22809270]
31. Bañares R, Catalina MV, Ripoll C, Rincón D. Prognostic markers in patients who have recovered from an acute variceal bleeding: role of HVPG measurement. Dis Markers 2011; 31: 165-169 [PMID: 22045402]
32. Seijo S, Reverter E, Miquel R, Berzigotti A, Abraldes JG, Bosch J, García-Pagán JC. Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension. Dig Liver Dis 2012; 44: 855-860 [PMID: 22721839]
33. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, Petrarca A, Moscarella S, Belli G, Zignego AL, Marra F, Laffi G, Pinzani M. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297 [PMID: 17464971 DOI: 10.1002/hep.21665]
34. Foucher J, Chanteloup E, Vergniol J, Castéra L, Le Bail B, Adhoute X, Bertet J, Couzigou P, de Lédinghen V. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-408 [PMID: 16020491 DOI: 10.1136/ gut.2005.069153]
35. Cho SB, Park KJ, Lee JS, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS, Kim SJ. Comparison of terlipressin and octreotide with variceal ligation for controlling acute esophageal variceal bleeding--a randomized prospective study. Korean J Hepatol 2006; 12: 385-393 [PMID: 16998290]
36. Youn KH, Kim DJ. Prevention of variceal bleeding and measurement of hepatic vein pressure gradient. Korean J Hepatol 2006; 12: 464-468 [PMID: 16998301]
37. Seo YS, Um SH, Hyun JJ, Kim YH, Park S, Keum BR, Kim YS, Jeen YT, Lee HS, Chun HJ, Lee SW, Choi JH, Kim CD, Ryu HS. A prospective study comparing the efficacy of early administration of terlipressin and somatostatin for the control of acute variceal bleeding in patients with cirrhosis. Korean J Hepatol 2006; 12: 373-384 [PMID: 16998289]
38. Castéra L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, Couzigou P, de Lédinghen V. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009; 50: 59-68 [PMID: 19013661 DOI: 10.1016/j.jhep.2008.08.018]
39. Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne-Carrie N, Kazemi F, Grando-Lemaire V, Trinchet JC, Beaugrand M. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther 2008; 28: 1102-1110 [PMID: 18691352 DOI: 10.1111/ j.1365-2036.2008.03825.x]
40. Kazemi F, Kettaneh A, N'kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, Beaugrand M. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006; 45: 230-235 [PMID: 16797100 DOI: 10.1016/j.jhep.2006.04.006]
41. Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, Rouquet O, Dupuis E, Alric L, Vinel JP. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008; 27: 1261-1268 [PMID: 18397389 DOI: 10.1111/j.1365-2036.2008.03701.x]
42. Pritchett S, Cardenas A, Manning D, Curry M, Afdhal NH. The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific. J Viral Hepat 2011; 18: e75-e80 [PMID: 21040236 DOI: 10.1111/ j.1365-2893.2010.01375.x]
43. Nguyen-Khac E, Saint-Leger P, Tramier B, Coevoet H, Capron D, Dupas JL. Noninvasive diagnosis of large esophageal varices by Fibroscan: strong influence of the cirrhosis etiology. Alcohol Clin Exp Res 2010; 34: 1146-1153 [PMID: 20477777]
44. Malik R, Lai M, Sadiq A, Farnan R, Mehta S, Nasser I, Challies T, Schuppan D, Afdhal N. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis. J Gastroenterol Hepatol 2010; 25: 1562-1568 [PMID: 20796156 DOI: 10.1111/ j.1440-1746.2010.06371.x]
45. Kim BK, Han KH, Park JY, Ahn SH, Kim JK, Paik YH, Lee KS, Chon CY, do Kim Y. A liver stiffness measurementbased, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol 2010; 105: 1382-1390 [PMID: 20087336 DOI: 10.1038/ajg.2009.750]
46. Kim BK, Park YN, do Kim Y, Park JY, Chon CY, Han KH, Ahn SH. Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement. Digestion 2012; 85: 219-227 [PMID: 22414567 DOI: 10.1159/000335430]
47. Kudo M. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy. Oncology 2008; 75 Suppl 1: 1-12 [PMID: 19092266 DOI: 10.1159/000181865]
48. El-Serag HB. Epidemiology of viral hepatitis and hepato-cellular carcinoma. Gastroenterology 2012; 142: 1264-1273. e1 [PMID: 22537432]
49. Frenette C, Gish R. Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications. World J Gastroenterol 2012; 18: 498-506 [PMID: 22363115 DOI: 10.3748/wjg.v18.i6.498]
50. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236 [PMID: 16250051 DOI: 10.1002/hep.20933]
51. Maggs JR, Suddle AR, Aluvihare V, Heneghan MA. Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma. Aliment Pharmacol Ther 2012; 35: 1113-1134 [PMID: 22432733 DOI: 10.1111/ j.1365-2036.2012.05072.x]
52. Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, Ohki T, Imamura J, Goto T, Kanai F, Kato N, Ikeda H, Shiina S, Kawabe T, Omata M. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 2009; 49: 1954-1961 [PMID: 19434742 DOI: 10.1002/hep.22870]
53. Jung KS, Kim SU, Ahn SH, Park YN, do Kim Y, Park JY, Chon CY, Choi EH, Han KH. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011; 53: 885-894 [PMID: 21319193 DOI: 10.1002/hep.24121]
54. Fung J, Lai CL, Seto WK, Wong DK, Yuen MF. Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B. J Viral Hepat 2011; 18: 738-744 [PMID: 20659306 DOI: 10.1111/ j.1365-2893.2010.01355.x]
55. Kim SU, Lee JH, do Kim Y, Ahn SH, Jung KS, Choi EH, Park YN, Han KH, Chon CY, Park JY. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One 2012; 7: e36676 [PMID: 22574212 DOI: 10.1371/journal.pone.0036676]
56. Chon YE, Jung ES, Park JY, do Kim Y, Ahn SH, Han KH, Chon CY, Jung KS, Kim SU. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B. J Clin Gastroenterol 2012; 46: 518-525 [PMID: 22688146 DOI: 10.1097/MCG.0b013e31825079f1]
57. Vergniol J, Foucher J, Castéra L, Bernard PH, Tournan R, Terrebonne E, Chanteloup E, Merrouche W, Couzigou P, de Lédinghen V. Changes of non-invasive markers and FibroScan values during HCV treatment. J Viral Hepat 2009; 16: 132-140 [PMID: 19175875 DOI: 10.1111/j.1365-2893.2008.01055.x]
58. Jung KS, Kim SU. Clinical applications of transient elastography. Clin Mol Hepatol 2012; 18: 163-173 [PMID: 22893866 DOI: 10.3350/cmh.2012.18.2.163]
59. Poca M, Puente A, Graupera I, Villanueva C. Prognostic markers in patients with cirrhosis and portal hypertension who have not bled. Dis Markers 2011; 31: 147-154 [PMID: 22045400]
60. Robic MA, Procopet B, Métivier S, Péron JM, Selves J, Vinel JP, Bureau C. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol 2011; 55: 1017-1024 [PMID: 21354450 DOI: 10.1016/j.jhep.2011.01.051]
61. Pesce A, Scilletta R, Branca A, Nigro L, Montineri A, Larocca L, Fatuzzo F, Castaing M, Puleo S. Does transient elastography (FibroScan®) have a role in decision making in hepatocellular carcinoma? HPB (Oxford) 2012; 14: 403-408 [PMID: 22568417]
62. Motosugi U, Ichikawa T, Koshiishi T, Sano K, Morisaka H, Ichikawa S, Enomoto N, Matsuda M, Fujii H, Araki T. Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary casecontrol study. Eur Radiol 2013; 23: 156-162 [PMID: 22814828]
63. Masuzaki R, Tateishi R, Yoshida H, Arano T, Uchino K, Enooku K, Goto E, Nakagawa H, Asaoka Y, Kondo Y, Goto T, Ikeda H, Shiina S, Omata M, Koike K. Assessment of disease progression in patients with transfusion-associated chronic hepatitis C using transient elastography. World J Gastroenterol 2012; 18: 1385-1390 [PMID: 22493553 DOI: 10.3748/wjg.v18. i12.1385]
64. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293 [PMID: 8690394 DOI: 10.1002/hep.510240201]
65. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-1417 [PMID: 7503362 DOI: 10.1097/00000478-199512000-00007]
66. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699 [PMID: 7560864 DOI: 10.1016/0168-8278(95)80226-6]
67. Kim SU, Ahn SH, Park JY, do Kim Y, Chon CY, Choi JS, Kim KS, Han KH. Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan(R) before curative resection of hepatocellular carcinoma: a pilot study. Hepatol Int 2008; 2: 471-477 [PMID: 19669322 DOI: 10.1007/ s12072-008-9091-0]
68. Kim SU, Kim YC, Choi JS, Kim KS, Choi GH, Choi JS, Park JY, do Kim Y, Ahn SH, Choi EH, Park YN, Chon CY, Han KH, Kim MJ. Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study. Magn Reson Imaging 2010; 28: 802-811 [PMID: 20395100 DOI: 10.1016/j.mri.2010.03.018]
69. Jung KS, Kim SU, Choi GH, Park JY, Park YN, do Kim Y, Ahn SH, Chon CY, Kim KS, Choi EH, Choi JS, Han KH. Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®). Ann Surg Oncol 2012; 19: 4278-4286 [PMID: 22752370]
70. Enomoto M, Mori M, Ogawa T, Fujii H, Kobayashi S, Iwai S, Morikawa H, Tamori A, Sakaguchi H, Sawada A, Takeda S, Habu D, Shiomi S, Kawada N. Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy. Hepatol Res 2010; 40: 853-861 [PMID: 20887589 DOI: 10.1111/j.1872-034X.2010.00687.x]
71. Kim SU, Park JY, do Kim Y, Ahn SH, Choi EH, Seok JY, Lee JM, Park YN, Chon CY, Han KH. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression. Hepatol Int 2010; 4: 673-680 [PMID: 21286337 DOI: 10.1007/s12072-010-9201-7]
72. Fung J, Lai CL, Wong DK, Seto WK, Hung I, Yuen MF. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study. J Viral Hepat 2011; 18: e200-e205 [PMID: 21692933 DOI: 10.1111/ j.1365-2893.2010.01428.x]
73. Lim SG, Cho SW, Lee YC, Jeon SJ, Lee MH, Cho YJ, Kim SS, Kim YB, Seok JY, Cheong JY, Kim JH. Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B. Hepatogastroenterology 2011; 58: 539-545 [PMID: 21661428]
74. Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, Chu SH, Chan FK, Sung JJ, Chan HL. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antivir Ther 2011; 16: 165-172 [PMID: 21447865 DOI: 10.3851/IMP1726]
75. Ogawa E, Furusyo N, Toyoda K, Takeoka H, Maeda S, Hayashi J. The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. Antiviral Res 2009; 83: 127-134 [PMID: 19443053 DOI: 10.1016/ j.antiviral.2009.04.002]
76. Wang JH, Changchien CS, Hung CH, Tung WC, Kee KM, Chen CH, Hu TH, Lee CM, Lu SN. Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan. J Gastroenterol Hepatol 2010; 25: 964-969 [PMID: 20546451 DOI: 10.1111/ j.1440-1746.2009.06194.x]
77. Arima Y, Kawabe N, Hashimoto S, Harata M, Nitta Y, Murao M, Nakano T, Shimazaki H, Kobayashi K, Ichino N, Osakabe K, Nishikawa T, Okumura A, Ishikawa T, Yoshioka K. Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C. Hepatol Res 2010; 40: 383-392 [PMID: 20236358 DOI: 10.1111/j.1872-034X.2009.00618.x]
78. Andersen ES, Weiland O, Leutscher P, Krarup H, Westin J, Moessner B, Konopski Z, Frigstad SO, Kjær M, Christensen PB, Weis N. Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs. Scand J Gastroenterol 2011; 46: 760-766 [PMID: 21438780 DOI: 10.3109/00365521.2011.565068]
79. Kim SU, Oh HJ, Park YN, Park JY, do Kim Y, Ahn SH, Chon CY, Han KH. Sub-classification of cirrhosis and prediction of liver-related events using fibroscan in patients with HBV-related cirrhosis. J Hepatol 2012; 56: s34 [DOI: 10.1016/ S0168-8278(12)60092-0]
80. Bae RC, Cho HJ, Oh JT, Lee EK, Heo J, Shin KY, Park SY, Jeong MK, Jeon SW, Cho CM, Tak WY, Kweon YO. Clinical factors influencing liver stiffness as measured by transient elastography (Fibroscan) in patients with chronic liver disease. Korean J Hepatol 2010; 16: 123-130 [PMID: 20606496 DOI: 10.3350/kjhep.2010.16.2.123]
81. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-973 [PMID: 17255218 DOI: 10.1136/gut.2006.111302]
82. Arena U, Vizzutti F, Abraldes JG, Corti G, Stasi C, Moscarella S, Milani S, Lorefice E, Petrarca A, Romanelli RG, Laffi G, Bosch J, Marra F, Pinzani M. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008; 57: 1288-1293 [PMID: 18448567 DOI: 10.1136/ gut.2008.149708]
83. Chan HL, Wong GL, Choi PC, Chan AW, Chim AM, Yiu KK, Chan FK, Sung JJ, Wong VW. Alanine aminotransferasebased algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009; 16: 36-44 [PMID: 18673426 DOI: 10.1111/ j.1365-2893.2008.01037.x]
84. Taylor-Robinson SD, Cobbold JF, Thomas HC. Liver stiffness measurements in acute hepatitis B: implications for clinical practice. Eur J Gastroenterol Hepatol 2010; 22: 133-134 [PMID: 20061829 DOI: 10.1097/MEG.0b013e328334250a]
85. Lee da M, Moon EJ, Hwang JA, Lee MS, Cheong JY, Cho SW, Kim YB, Kim DJ, Hwang SG, Yang JM. Factors associated with liver stiffness in chronic liver disease. Korean J Hepatol 2009; 15: 464-473 [PMID: 20037265]
86. Viganò M, Massironi S, Lampertico P, Iavarone M, Paggi S, Pozzi R, Conte D, Colombo M. Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B. Eur J Gastroenterol Hepatol 2010; 22: 180-184 [PMID: 19855283 DOI: 10.1097/MEG.0b013e328332d2fa]
87. Sagir A, Erhardt A, Schmitt M, Häussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47: 592-595 [PMID: 18098325 DOI: 10.1002/hep.22056]
88. Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, Chan FK, Sung JJ, Chan HL. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol 2009; 24: 1002-1007 [PMID: 19457152 DOI: 10.1111/ j.1440-1746.2009.05779.x]
89. Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, Moscarella S, Boddi V, Petrarca A, Laffi G, Marra F, Pinzani M. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47: 380-384 [PMID: 18095306 DOI: 10.1002/hep.22007]
90. Kim SU, Kim JK, Park YN, Han KH. Discordance between liver biopsy and Fibroscan® in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation. PLoS One 2012; 7: e32233 [PMID: 22384189 DOI: 10.1371/journal.pone.0032233]
91. Fung J, Lai CL, But D, Hsu A, Seto WK, Cheng C, Wong DK, Yuen MF. Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B. Hepatol Int 2010; 4: 716-722 [PMID: 21286342 DOI: 10.1007/s12072-010-9189-z]
92. Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007; 14: 360-369 [PMID: 17439526 DOI: 10.1111/j.1365-2893.2006.00811.x]
93. Oliveri F, Coco B, Ciccorossi P, Colombatto P, Romagnoli V, Cherubini B, Bonino F, Brunetto MR. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol 2008; 14: 6154-6162 [PMID: 18985805 DOI: 10.3748/ wjg.14.6154]
94. Park H, Kim SU, Kim D, do Kim Y, Ahn SH, Han KH, Chon CY, Park JY. Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation. J Clin Gastroenterol 2012; 46: 602-607 [PMID: 22772739 DOI: 10.1097/ MCG.0b013e3182582a31]
95. Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Büchler MW, Seitz HK, Mueller S. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008; 48: 1718-1723 [PMID: 18836992 DOI: 10.1002/hep.22577]
96. Colli A, Pozzoni P, Berzuini A, Gerosa A, Canovi C, Molteni EE, Barbarini M, Bonino F, Prati D. Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology 2010; 257: 872-878 [PMID: 20935077 DOI: 10.1148/radiol.10100013]
97. Hopper I, Kemp W, Porapakkham P, Sata Y, Condon E, Skiba M, Farber L, Porapakkham P, Williams TJ, Menahem S, Roberts S, Krum H. Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography. Eur J Heart Fail 2012; 14: 621-627 [PMID: 22523374 DOI: 10.1093/eurjhf/hfs044]
98. Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, Stiefel P, Pöschl G, Büchler MW, Seitz HK, Mueller S. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010; 52: 206-210 [PMID: 20022130 DOI: 10.1016/j.jhep.2009.11.018]
99. Foucher J, Castéra L, Bernard PH, Adhoute X, Laharie D, Bertet J, Couzigou P, de Lédinghen V. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006; 18: 411-412 [PMID: 16538113 DOI: 10.1097/00042737-200604000-00015]
100. de Lédinghen V, Wong VW, Vergniol J, Wong GL, Foucher J, Chu SH, Le Bail B, Choi PC, Chermak F, Yiu KK, Merrouche W, Chan HL. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. J Hepatol 2012; 56: 833-839 [PMID: 22173167 DOI: 10.1016/j.jhep.2011.10.017]